303 related articles for article (PubMed ID: 28939187)
1. The ameliorative effects and underlying mechanisms of dopamine D1-like receptor agonist SKF38393 on Aβ
Zang X; Cheng ZY; Sun Y; Hua N; Zhu LH; He L
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():250-261. PubMed ID: 28939187
[TBL] [Abstract][Full Text] [Related]
2. Risperidone ameliorated Aβ
Wu L; Feng X; Li T; Sun B; Khan MZ; He L
Behav Brain Res; 2017 Mar; 322(Pt A):145-156. PubMed ID: 28093254
[TBL] [Abstract][Full Text] [Related]
3. Roles of dopamine receptor subtypes in mediating modulation of T lymphocyte function.
Huang Y; Qiu AW; Peng YP; Liu Y; Huang HW; Qiu YH
Neuro Endocrinol Lett; 2010; 31(6):782-91. PubMed ID: 21196914
[TBL] [Abstract][Full Text] [Related]
4. Involvement of dopamine receptors in beneficial effects of tachykinins on scopolamine-induced impairment of alternation performance in mice.
Ukai M; Shinkai N; Kameyama T
Eur J Pharmacol; 1998 May; 350(1):39-45. PubMed ID: 9683012
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the effects of the cannabinoid agonist, ACPA, on spatial and non-spatial novelty detection in mice by dopamine D1 receptor drugs infused into the basolateral amygdala.
Mohammadi M; Nasehi M; Zarrindast MR
Behav Brain Res; 2015 Mar; 280():36-44. PubMed ID: 25476564
[TBL] [Abstract][Full Text] [Related]
6. Blockade of the dorsal hippocampal dopamine D1 receptors inhibits the scopolamine-induced state-dependent learning in rats.
Piri M; Rostampour M; Nasehi M; Zarrindast MR
Neuroscience; 2013 Nov; 252():460-7. PubMed ID: 23933216
[TBL] [Abstract][Full Text] [Related]
7. Activation of dopamine D1 receptors in the medial septum improves scopolamine-induced amnesia in the dorsal hippocampus.
Zarrindast MR; Ardjmand A; Ahmadi S; Rezayof A
Behav Brain Res; 2012 Apr; 229(1):68-73. PubMed ID: 22226623
[TBL] [Abstract][Full Text] [Related]
8. D1/D5 dopamine receptors modulate spatial memory formation.
da Silva WC; Köhler CC; Radiske A; Cammarota M
Neurobiol Learn Mem; 2012 Feb; 97(2):271-5. PubMed ID: 22266268
[TBL] [Abstract][Full Text] [Related]
9. Notoginseng Saponin Rg1 Prevents Cognitive Impairment through Modulating APP Processing in Aβ
Liu SZ; Cheng W; Shao JW; Gu YF; Zhu YY; Dong QJ; Bai SY; Wang P; Lin L
Curr Med Sci; 2019 Apr; 39(2):196-203. PubMed ID: 31016510
[TBL] [Abstract][Full Text] [Related]
10. Activation of adenosine A1 receptor modulates dopamine D1 receptor activity in stably cotransfected human embryonic kidney 293 cells.
Cao Y; Sun WC; Jin L; Xie KQ; Zhu XZ
Eur J Pharmacol; 2006 Oct; 548(1-3):29-35. PubMed ID: 16956604
[TBL] [Abstract][Full Text] [Related]
11. Consolidation of object recognition memory requires simultaneous activation of dopamine D1/D5 receptors in the amygdala and medial prefrontal cortex but not in the hippocampus.
Rossato JI; Radiske A; Kohler CA; Gonzalez C; Bevilaqua LR; Medina JH; Cammarota M
Neurobiol Learn Mem; 2013 Nov; 106():66-70. PubMed ID: 23891712
[TBL] [Abstract][Full Text] [Related]
12. Chronic constant light-induced hippocampal late-phase long-term potentiation impairment in vitro is attenuated by antagonist of D1/D5 receptors.
Chai AP; Ma WP; Wang LP; Cao J; Xu L; Yang YX; Mao RR
Brain Res; 2015 Oct; 1622():72-80. PubMed ID: 26115584
[TBL] [Abstract][Full Text] [Related]
13. Effects of ventral pallidal D1 dopamine receptor activation on memory consolidation in morris water maze test.
Péczely L; Ollmann T; László K; Kovács A; Gálosi R; Szabó A; Karádi Z; Lénárd L
Behav Brain Res; 2014 Nov; 274():211-8. PubMed ID: 25138696
[TBL] [Abstract][Full Text] [Related]
14. D(1) receptor agonists reverse the subchronic phencyclidine (PCP)-induced novel object recognition (NOR) deficit in female rats.
Horiguchi M; Hannaway KE; Adelekun AE; Huang M; Jayathilake K; Meltzer HY
Behav Brain Res; 2013 Feb; 238():36-43. PubMed ID: 23018127
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D1 receptor agonist A-68930 ameliorates Aβ
Cheng ZY; Xia QP; Hu YH; Wang C; He L
Int Immunopharmacol; 2020 Nov; 88():106963. PubMed ID: 33182028
[TBL] [Abstract][Full Text] [Related]
16. Requirement for the endocannabinoid system in social interaction impairment induced by coactivation of dopamine D1 and D2 receptors in the piriform cortex.
Zenko M; Zhu Y; Dremencov E; Ren W; Xu L; Zhang X
J Neurosci Res; 2011 Aug; 89(8):1245-58. PubMed ID: 21557291
[TBL] [Abstract][Full Text] [Related]
17. Role of D1 dopamine receptors of the ventral pallidum in inhibitory avoidance learning.
Péczely L; Ollmann T; László K; Kovács A; Gálosi R; Szabó Á; Karádi Z; Lénárd L
Behav Brain Res; 2014 Aug; 270():131-6. PubMed ID: 24815313
[TBL] [Abstract][Full Text] [Related]
18. Synergistic interactions of dopamine D1 and glutamate NMDA receptors in rat hippocampus and prefrontal cortex: involvement of ERK1/2 signaling.
Sarantis K; Matsokis N; Angelatou F
Neuroscience; 2009 Nov; 163(4):1135-45. PubMed ID: 19647050
[TBL] [Abstract][Full Text] [Related]
19. Kidney dopamine D
Banday AA; Diaz AD; Lokhandwala M
Am J Physiol Renal Physiol; 2019 Oct; 317(4):F949-F956. PubMed ID: 31411069
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of kinetin against aluminum chloride and D-galactose induced cognitive impairment and oxidative damage in mouse.
Wei Y; Liu D; Zheng Y; Li H; Hao C; Ouyang W
Brain Res Bull; 2017 Sep; 134():262-272. PubMed ID: 28867383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
